Two Small Molecules Show Promise as Broad-Spectrum Coronavirus Inhibitors in Laboratory Study
Researchers found that sennoside A and ceftazidime, two small molecules, can inhibit RNA binding in the nucleocapsid proteins of SARS-CoV-2, SARS-CoV, and MERS-CoV in laboratory experiments. The nucleocapsid protein is highly conserved across coronaviruses and essential for viral replication, making it a potential drug target. The findings suggest these compounds could form the basis for pan-coronavirus antiviral therapies, though further development and clinical testing would be needed.
A preprint study published on bioRxiv reports that sennoside A and ceftazidime inhibit nucleocapsid RNA binding across three major human coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV. The researchers purified recombinant nucleocapsid (N) proteins from all three viruses and used electrophoretic mobility shift assays and fluorescence polarization to demonstrate that both compounds significantly reduced RNA binding capacity. Molecular docking analyses indicated that both inhibitors target the RNA-binding pocket of the N-terminal domain through a conserved mechanism. The study builds on earlier work identifying these compounds and reveals that key residues involved in inhibitor binding are conserved across betacoronaviruses, suggesting a shared vulnerability that could be exploited therapeutically. The authors propose these findings highlight the potential for developing broad-spectrum antiviral strategies targeting the nucleocapsid protein.
What's missing
This is a preprint study that has not undergone peer review. The research is limited to in vitro laboratory experiments using purified proteins and does not include cell culture or animal studies demonstrating antiviral efficacy in living systems. Clinical translation and safety profiles remain unknown. The study does not address whether these compounds can cross cellular membranes or achieve therapeutic concentrations in infected organisms.
What different sources said
- bioRxivCenter
Sennoside A and Ceftazidime Inhibit Nucleocapsid RNA BindingAcross SARS-CoV-2, SARS-CoV, and MERS-CoV
Related
Study Shows Statins Reduce Coenzyme Q in Brain Cells, Impairing Mitochondrial Function
A laboratory study found that statin drugs decrease coenzyme Q levels in astrocytes (brain support cells) by 30-40%, reducing their mitochondrial energy production and increasing oxidative stress. Astrocytes are critical for maintaining brain health and protecting neurons from damage. The findings suggest CoQ10 supplementation may help counteract these effects, though human clinical evidence remains limited.
Study reveals zebrafish larvae exhibit slowly fluctuating directional swim biases driven by internal dynamics
Researchers found that 5-day-old zebrafish larvae display changing directional swim preferences over many hours even in stable environments, contrary to classical models assuming constant individual biases. Computational analysis suggests these fluctuations arise from a non-stationary Markovian process with two independent internal input streams modulating swim direction repetition. The findings suggest animals possess intrinsic mechanisms for generating behavioral variability independent of external stimuli, with implications for understanding how internal states shape adaptive behavior.
Fish skin microbiomes shift dramatically as species transition from aquatic to terrestrial habitats
Researchers studying three combtooth blenny fish species found that their skin microbiomes diverge significantly based on habitat, with the most terrestrial species showing the most distinct microbial communities. The study compared skin bacteria across species occupying different zones of the intertidal gradient in Guam, from fully aquatic to exclusively terrestrial environments. The findings suggest microbial symbionts may play a role in enabling amphibious lifestyles and provide insights into how microbiomes respond to environmental change.